Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01257308
Recruitment Status : Unknown
Verified December 2010 by Taipei Medical University WanFang Hospital. Recruitment status was: Enrolling by invitation
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Lung Cancer Patients
20 or more than 20 years of age
The pathological diagnosis confirmed lung cancer
Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue specimens
The patient had signed inform consent
pleural effusion or tumor tissue can not be obtained
the patient is not suitable to join the research according to the judgement by the investigator